Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia.
K
K
Prabhash
Ghanshyam
G
Biswas
N
N
Prasad
Narayan
N
Karant
P S R K
PS
Sastry
P M
PM
Parikh
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001549:Benzamides; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D009260:Nail Diseases / Q000139:chemically induced*; D009262:Nails / Q000187:drug effects; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate